Applications of tumor neoantigens to precision immunotherapy
10. 3760/cma. j. issn. 0254-5101. 2018. 05. 010
- VernacularTitle:肿瘤新抗原在肿瘤精准免疫治疗中的应用
- Author:
Airong WANG
1
,
2
;
Gaofeng JIANG
;
Yu-Fang MA
Author Information
1. 430064 武汉科技大学附属天佑医院转化医学中心
2. 430064 武汉科技大学附属天佑医院肿瘤免疫治疗研究所
- Keywords:
Tumor neoantigen;
Tumor-specific antigen;
Immunotherapy;
Personalized vaccine
- From:
Chinese Journal of Microbiology and Immunology
2018;38(5):390-394
- CountryChina
- Language:Chinese
-
Abstract:
Tumor neoantigens generated from somatic mutations can be presented by major histo-compability complex (MHC) molecules and elicit specific immune response against cancer. Therapeutic vac-cines and specific T cells targeting tumor neoantigens will realize the potential of precision immunotherapy in cancer treatment. Along with the development of methods for predicting neoantigens, individualized cancer immunotherapy strategies will be widely adopted. In the present review, we discuss the current state of the prediction approaches and clinical applications of neoantigens, as well as the challenges that remain to be ad-dressed in order to improve immunotherapy targeting neoantigens.